Orasis Pharmaceuticals Submits New Drug Application for Investigational Novel Eye Drop Candidate, CSF-1, for the Treatment of Presbyopia

Ponte Vedra, FL, January 3, 2023– Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing a unique eye drop to improve near vision for people with presbyopia, today announced that it has submitted a New...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news